Staphylococcus epidermidis

(redirected from S. epidermidis)

Staph·y·lo·coc·cus ep·i·derm·i·dis

a species of bacteria, the most common of the coagulase-negative Staphylococcus group.

Staphylococcus epidermidis

Microbiology A coagulase-negative staphylococcus that comprises up to 80% of clinical isolates Infections by S epidermidis Infective endocarditis, IV catheter infections, bacteremia, CSF shunt infections, UTIs, osteomyelitis, vascular graft infections, prosthetic joint infections

Staphylococcus epidermidis

coagulase-negative pathogen; forms part of normal skin flora

Staphylococcus

a genus of spherical, gram-positive bacteria tending to occur in grapelike clusters; they are normal flora on the skin and in the upper respiratory tract and are the most common cause of localized suppurating infections. Pathogenic species are characterized by positive reactions to the coagulase test.

Staphylococcus aureus
a common and important cause of disease in animals including bovine mastitis, tick pyemia (enzootic staphylococcosis), abscesses, dermatitis, furunculosis, meningitis, osteomyelitis, food poisoning, wound suppuration, and bumblefoot in poultry. S. aureus subsp. anaerobius causes lesions similar to caseous lymphadenitis in sheep.
Staphylococcus epidermidis
a common skin and mucosal inhabitant in humans and occasionally in animals living in association with humans.
Staphylococcus hyicus (Staphylococcus hyos)
causes exudative epidermitis and occasionally septic arthritis in pigs.
Staphylococcus intermedius
the major isolate from pyoderma and occasionally other pyogenic infections in dogs and cats and a rare cause of infection in other species.
Staphylococcus xylosus
a rare cause of mastitis in cattle.
References in periodicals archive ?
Many of the discrepancies were related to organisms of little relative clinical significance, such as S.
To our knowledge, in Portugal only 1 linezolid-resistant S.
aureus OA/Ap 70 20 24 2 UA/Ap 30 5 24 2 OA/Ox 70 30 10 5 UA/Ox 30 8 10 4 S.
Methods : A total of 132 coagulase negative staphylococci from cases of infectious keratitis were identified as S.
Nabi Biopharmaceuticals (Rockville, MD) has been granted United States Patent 6,936,258 entitled "Staphylococcus Antigen and Vaccine" by the United States Patent and Trademark Office for the composition of a strategically important glycoprotein-based antigen (GP-1) associated with three Staphylococcal strains: S.
Two days later, on the weekend, both cultures grow S.
We show that a 1-week course of clarithromycin selects for macrolide-resistant S.
senior vice president, clinical, medical and regulatory affairs, Nabi Biopharmaceuticals, stated, "Patients most at risk of contracting S.
Recently, 2 cases of bloodstream infections caused by SCVs of S.
Already during the fourth quarter of 2004, Nabi Biopharmaceuticals has completed formulation of a clinical lot of its S.
Although considered a contaminant, we observed that S.